Published in PLoS One on April 16, 2008
Colloquium paper: uniquely human evolution of sialic acid genetics and biology. Proc Natl Acad Sci U S A (2010) 2.30
In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood (2010) 2.17
Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci (2012) 2.09
Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci (2009) 2.04
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 2.03
Multiple changes in sialic acid biology during human evolution. Glycoconj J (2008) 1.43
Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS (2010) 1.34
Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. PLoS Pathog (2013) 1.19
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood (2009) 1.15
Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni. J Immunol (2012) 1.14
Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect Immun (2010) 1.13
Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS One (2011) 1.10
Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages. PLoS One (2011) 1.08
Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry. Nat Protoc (2010) 1.07
Sialoadhesin in recognition of self and non-self. Semin Immunopathol (2012) 1.05
Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS One (2012) 1.04
CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells. J Immunol (2010) 1.04
HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1. PLoS Pathog (2014) 1.03
Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation. Immunology (2013) 1.02
Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages. Front Immunol (2015) 0.99
The interplay between Siglecs and sialylated pathogens. Glycobiology (2014) 0.96
HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells. Scientifica (Cairo) (2013) 0.93
Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation. J Allergy Clin Immunol (2015) 0.90
HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells. Retrovirology (2015) 0.89
Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects. J Virol (2014) 0.87
NK Cell Subset Redistribution during the Course of Viral Infections. Front Immunol (2014) 0.86
CD169-dependent cell-associated HIV-1 transmission: a driver of virus dissemination. J Infect Dis (2014) 0.85
Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment. PLoS One (2013) 0.84
Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes. PLoS One (2012) 0.84
Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein. J Biol Chem (2011) 0.84
Blocking porcine sialoadhesin improves extracorporeal porcine liver xenoperfusion with human blood. Xenotransplantation (2013) 0.83
Multivalent ligands for siglecs. Methods Enzymol (2010) 0.83
Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region. J Leukoc Biol (2015) 0.83
Refolded recombinant Siglec5 for NMR investigation of complex carbohydrate binding. Protein Expr Purif (2013) 0.81
A mechanistic overview of dendritic cell-mediated HIV-1 trans infection: the story so far. Future Virol (2015) 0.81
Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa. J Acquir Immune Defic Syndr (2010) 0.81
Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection. Stem Cell Res (2015) 0.80
Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus. J Mol Med (Berl) (2014) 0.80
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation. J Leukoc Biol (2015) 0.79
A new tool for detection of type I interferon activation in systemic lupus erythematosus. Arthritis Res Ther (2010) 0.78
The role of Siglec-1 and SR-BI interaction in the phagocytosis of oxidized low density lipoprotein by macrophages. PLoS One (2013) 0.78
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages. Retrovirology (2013) 0.78
Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS. AIDS Res Hum Retroviruses (2015) 0.78
Enhanced N-glycosylation site exploitation of sialoglycopeptides by peptide IPG-IEF assisted TiO2 chromatography. Glycoconj J (2012) 0.77
Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages. Infect Immun (2013) 0.77
A consensus surface activation marker signature is partially dependent on human immunodeficiency virus type 1 Nef expression within productively infected macrophages. Retrovirology (2013) 0.76
Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infection. Curr HIV Res (2014) 0.76
Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS One (2016) 0.75
Identification of Siglec-1 null individuals infected with HIV-1. Nat Commun (2016) 0.75
Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated. Virology (2016) 0.75
Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury. Dig Dis Sci (2016) 0.75
Genetic resistance - an alternative for controlling PRRS? Porcine Health Manag (2016) 0.75
Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates. Front Immunol (2017) 0.75
Viruses exploit the tissue physiology of the host to spread in vivo. Curr Opin Cell Biol (2016) 0.75
PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo. PLoS One (2016) 0.75
Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of IFN-α. J Virol (2017) 0.75
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 14.43
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother (2002) 13.91
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell (1996) 6.52
A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science (2005) 5.88
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med (1997) 5.18
DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity (2002) 4.62
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A (1999) 4.46
Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science (2005) 4.12
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother (2000) 3.28
Activation of lysosomal function during dendritic cell maturation. Science (2003) 3.22
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol (1996) 2.75
CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol (2001) 2.30
Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses (1991) 2.29
Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood (2001) 2.25
Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol (2001) 2.24
Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity (2003) 1.86
Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J (1991) 1.79
Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest (2005) 1.78
Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J Exp Med (1992) 1.78
Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet (1972) 1.73
Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J Virol (2003) 1.72
Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J Virol (2006) 1.67
Human natural interferon-alpha producing cells. Pharmacol Ther (1993) 1.61
Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol (2000) 1.58
HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology (2005) 1.54
Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. J Clin Invest (1991) 1.52
Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J Virol (2006) 1.38
Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol (2004) 1.32
Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection. Clin Exp Immunol (2000) 1.32
Cytokine network and acute primary HIV-1 infection. AIDS (1993) 1.28
Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1). J Immunol (2001) 1.28
Monocyte-derived dendritic cells. Semin Immunol (2005) 1.27
Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol (2005) 1.26
Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol (2006) 1.24
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J Biol Chem (2005) 1.23
Siglecs: a family of sialic-acid binding lectins. Glycobiology (1998) 1.22
Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression. PLoS One (2007) 1.21
Sialic acid binding receptors (siglecs) expressed by macrophages. J Leukoc Biol (1999) 1.17
Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process. Virology (2001) 1.00
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex. Proc Natl Acad Sci U S A (1999) 0.96
TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol (2008) 3.02
Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med (2012) 2.43
Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost (2002) 2.16
Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J Clin Invest (2006) 2.02
ECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1). Nat Immunol (2011) 1.54
Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Cell Res (2013) 1.54
Spontaneous breathing with biphasic positive airway pressure attenuates lung injury in hydrochloric acid-induced acute respiratory distress syndrome. Anesthesiology (2014) 1.53
Concern Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine. PLoS One (2010) 1.51
Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral load. J Am Chem Soc (2011) 1.51
HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS (2005) 1.47
Outcomes in treatment for primary spinal anaplastic ependymomas: a retrospective series of 20 patients. J Neurosurg Spine (2013) 1.41
Respiratory care practices and requirements for respiratory therapists in Beijing intensive care units. Respir Care (2011) 1.41
Unusual architecture of the p7 channel from hepatitis C virus. Nature (2013) 1.39
Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis Markers (2011) 1.36
Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS (2010) 1.34
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis (2012) 1.32
Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol (2004) 1.32
Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J Virol (2010) 1.30
PEDV ORF3 encodes an ion channel protein and regulates virus production. FEBS Lett (2012) 1.29
Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One (2010) 1.29
Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients. J Mol Biol (2004) 1.26
The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus. J Gen Virol (2014) 1.26
IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One (2012) 1.25
Negative regulation of Toll-like receptor signaling pathway. Microbes Infect (2009) 1.22
High density lipoprotein uptake by scavenger receptor SR-BII. J Biol Chem (2004) 1.21
Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment. Nat Immunol (2009) 1.19
Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. J Immunol (2010) 1.19
The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells. Cell Res (2004) 1.18
Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J Immunol (2003) 1.18
Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito. Blood (2007) 1.16
Cilostazol as a unique antithrombotic agent. Curr Pharm Des (2003) 1.13
Modification of nonstructural protein 1 of influenza A virus by SUMO1. J Virol (2010) 1.13
Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease. PLoS One (2009) 1.07
Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci U S A (2006) 1.07
Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study. Crit Care (2014) 1.07
Viral proteins function as ion channels. Biochim Biophys Acta (2010) 1.07
Epigenetic modification and inheritance in sexual reversal of fish. Genome Res (2014) 1.05
Chemical and physical modifications to poly(dimethylsiloxane) surfaces affect adhesion of Caco-2 cells. J Biomed Mater Res A (2010) 1.05
Amino acids 473V and 598P of PB1 from an avian-origin influenza A virus contribute to polymerase activity, especially in mammalian cells. J Gen Virol (2011) 1.03
Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection. J Neurovirol (2010) 1.02
Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. AIDS (2002) 1.01
A novel NF-kappaB binding site controls human granzyme B gene transcription. J Immunol (2006) 0.99
Identification of an epitope of SARS-coronavirus nucleocapsid protein. Cell Res (2003) 0.98
Antibody responses to individual proteins of SARS coronavirus and their neutralization activities. Microbes Infect (2005) 0.98
Dec2 promotes Th2 cell differentiation by enhancing IL-2R signaling. J Immunol (2009) 0.97
IFN-gamma up-regulation of IL-12 beta 2 receptor is associated with experimental autoimmune uveitis susceptible B10.A mice, but not in EAU resistant BALB/c mice. J Neuroimmunol (2003) 0.95
Increased robustness of single-molecule counting with microfluidics, digital isothermal amplification, and a mobile phone versus real-time kinetic measurements. Anal Chem (2013) 0.94
Suppressed monocyte gene expression profile in men versus women with PTSD. Brain Behav Immun (2010) 0.94
Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunol (2011) 0.93
Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition. Cancer Res (2009) 0.93
GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. Thromb Res (2005) 0.92
Adipose tissue-derived stromal cells express neuronal phenotypes. Chin Med J (Engl) (2004) 0.92
Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. J Virol Methods (2011) 0.92
Characterization of low-pathogenic H6N6 avian influenza viruses in central China. Arch Virol (2012) 0.92
Th1/Th2 cell's function in immune system. Adv Exp Med Biol (2014) 0.92
Global NeuroAIDS roundtable. J Neurovirol (2013) 0.92
Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection. J Acquir Immune Defic Syndr (2013) 0.91
Novel function of IFN-gamma: negative regulation of dendritic cell migration and T cell priming. J Immunol (2006) 0.90
Negative regulation of Nmi on virus-triggered type I IFN production by targeting IRF7. J Immunol (2013) 0.89
Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus. Biochem Biophys Res Commun (2005) 0.89
Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand. J Neuroimmunol (2008) 0.89
Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology (2011) 0.89
A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations. AIDS (2011) 0.89
Effect of spontaneous breathing on ventilator-induced lung injury in mechanically ventilated healthy rabbits: a randomized, controlled, experimental study. Crit Care (2011) 0.89
Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J Immunol (2013) 0.88
design of multiplexed detection assays for identification of avian influenza a virus subtypes pathogenic to humans by SmartCycler real-time reverse transcription-PCR. J Clin Microbiol (2008) 0.88
Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient. Virology (2012) 0.88
Telomere deficiencies on chromosomes 9p, 15p, 15q and Xp: potential biomarkers for breast cancer risk. Hum Mol Genet (2010) 0.88
Negative regulation of NLRP3 inflammasome signaling. Protein Cell (2013) 0.87
Sirt2 suppresses inflammatory responses in collagen-induced arthritis. Biochem Biophys Res Commun (2013) 0.87
Digital biology and chemistry. Lab Chip (2014) 0.87
In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse. PLoS One (2010) 0.87
Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7. J Immunol (2011) 0.87
Current understanding of Th2 cell differentiation and function. Protein Cell (2011) 0.86
Microwave-assisted synthesis of mesoporous Co3O4 nanoflakes for applications in lithium ion batteries and oxygen evolution reactions. ACS Appl Mater Interfaces (2015) 0.86
Antagonist of peroxisome proliferator-activated receptor gamma induces cerebellar amyloid-beta levels and motor dysfunction in APP/PS1 transgenic mice. Biochem Biophys Res Commun (2009) 0.85
Toll-like receptor-initiated testicular innate immune responses in mouse Leydig cells. Endocrinology (2011) 0.85
Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein. Virol J (2012) 0.84
A novel adipocytokine visfatin protects against H(2)O(2) -induced myocardial apoptosis: a missing link between obesity and cardiovascular disease. J Cell Physiol (2013) 0.84
Estrogen receptor mediates the effects of pseudoprotodiocsin on adipogenesis in 3T3-L1 cells. Am J Physiol Cell Physiol (2010) 0.84
Expression of intracellular domain of epidermal growth factor receptor and generation of its monoclonal antibody. Cell Mol Immunol (2004) 0.84
Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation. J Biol Chem (2013) 0.84
Severe acute respiratory syndrome coronavirus accessory protein 9b is a virion-associated protein. Virology (2009) 0.84
Rapid microfluidic perfusion enabling kinetic studies of lipid ion channels in a bilayer lipid membrane chip. Ann Biomed Eng (2011) 0.84
Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment. PLoS One (2013) 0.84
Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells. Int J Clin Exp Pathol (2013) 0.84
Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody. Virology (2008) 0.84
An activity-based probe reveals dynamic protein-protein interactions mediating IGF-1R transactivation by the GABA(B) receptor. Biochem J (2012) 0.83
Cellular localization of NLRP3 inflammasome. Protein Cell (2013) 0.83
Effect of sex hormones on experimental autoimmune uveoretinitis (EAU). Immunol Invest (2003) 0.83